CreakyJoints.org

We can all agree that things have been pretty unpredictable on Twitter lately.

Please stay in touch with us here: creakyjoints.org/creakychats/

Five research posters, one podium presentation, and a very busy day at #ACR2026!
@GHLForg’s @SethSaidSo, @AngelaDegrassi, and @venkyshilpa1 found a moment to smile in the poster hall between conversations about research, patient experiences, and the future of rheumatology care.
We’re proud to see so much patient-centered research represented at this year’s meeting. Even prouder of the patients who make this work possible.
Lots of science. Lots of conversations. And plenty of comfortable shoes required.
#ACR2026 #PatientCenteredResearch #Rheumatology #GHLF

@GHLForg’s @AngelaDegrassi is at #ACR2026 presenting research on identifying knowledge gaps in polymyalgia rheumatica (PMR).

By bringing patient perspectives and clinical expertise together, this work aims to help shape future research and improve care.

#Rheumatology

What matters most to people living with inflammatory conditions when it comes to treatment?

According to new research from @GHLForg, the answer may be simpler than we think: pain relief.

In a survey of 808 people living with inflammatory conditions, reducing pain emerged as a greater priority than achieving clinical remission.

While remission remains an important medical goal, these findings highlight a critical distinction between how treatment success is measured clinically and what patients experience in their everyday lives.

For someone managing chronic inflammation, success may mean being able to get out of bed comfortably, return to work, spend time with family, or make plans without worrying about pain.

The research, presented at ACR Convergence 2026, reinforces why patient-reported outcomes and shared decision-making deserve a central role in treatment conversations.

Because effective care isn't just about improving clinical measurements. It's also about improving people's lives.

What matters most to you when evaluating whether a treatment is working?

Read more about the findings: creakyjoints.org/acr-2026/patie…

#ACR26 #ChronicPain #Rheumatology #PatientCenteredCare

For years, managing rheumatoid arthritis (RA) and fibromyalgia meant navigating chronic pain, unpredictable flares, and the challenges of everyday life for Shelley Fritz.

Then something unexpected happened.

After starting tirzepatide, a GLP-1–based medication, Shelley began noticing significant changes in her pain, RA flares, and daily functioning.

Her experience became the focus of a patient-perspective poster presented by the @GHLForg at ACR Convergence 2026.

The poster documents her self-reported improvements and raises important questions about the potential relationship between GLP-1 medications, inflammation, and chronic pain.

Patient experiences like hers can help identify questions worth exploring through future research.

Read Shelley's story and learn more about the findings presented at #ACR26:

creakyjoints.org/acr-2026/rheum…

#RheumatoidArthritis #GLP1 #ChronicPain #Rheumatology